These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22249956)

  • 21. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.
    Milloy MJ; Kerr T; Bangsberg DR; Buxton J; Parashar S; Guillemi S; Montaner J; Wood E
    AIDS Patient Care STDS; 2012 Jan; 26(1):60-7. PubMed ID: 22107040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
    Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
    Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.
    Rebeiro PF; Abraham AG; Horberg MA; Althoff KN; Yehia BR; Buchacz K; Lau BM; Sterling TR; Gange SJ
    AIDS Patient Care STDS; 2017 Mar; 31(3):129-144. PubMed ID: 28282246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
    Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
    BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study.
    Cescon A; Patterson S; Chan K; Palmer AK; Margolese S; Burchell AN; Cooper C; Klein MB; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Raboud JM; Loutfy MR;
    PLoS One; 2013; 8(12):e83649. PubMed ID: 24391803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.
    Jordan MR; Obeng-Aduasare Y; Sheehan H; Hong SY; Terrin N; Duong DV; Trung NV; Wanke C; Kinh NV; Tang AM
    Int J STD AIDS; 2014 Aug; 25(9):662-668. PubMed ID: 24352130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active injection drug-abuse offsets healthcare engagement in HIV-infected patients.
    Liappis AP; Laake AM; Delman M
    AIDS Behav; 2015 Jan; 19(1):81-4. PubMed ID: 24710959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiretroviral treatment discontinuation and its influencing factors among HIV-infected patients who initiated ART from 2012 to 2015 in Wenshan prefecture, Yunnan Province].
    Hu XS; Zhao Y; Huang LL; Luo YX; Wu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):982-987. PubMed ID: 29136742
    [No Abstract]   [Full Text] [Related]  

  • 36. Does initiation of HIV antiretroviral therapy influence patterns of syringe lending among injection drug users?
    Kuyper L; Milloy MJ; Marshall BD; Zhang R; Kerr T; Montaner JS; Wood E
    Addict Behav; 2011 May; 36(5):560-3. PubMed ID: 21320757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.
    Westergaard RP; Ambrose BK; Mehta SH; Kirk GD
    J Int AIDS Soc; 2012 Feb; 15(1):10. PubMed ID: 22360788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.